United States Cytotoxic Drug Market Report & Forecast 2021-2027

United States Cytotoxic Drug Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Cytotoxic Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Cytotoxic Drug Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Cytotoxic Drug Overall Market Size
2.1 United States Cytotoxic Drug Market Size: 2021 VS 2027
2.2 United States Cytotoxic Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cytotoxic Drug Players in United States Market
3.2 Top United States Cytotoxic Drug Companies Ranked by Revenue
3.3 United States Cytotoxic Drug Revenue by Companies
3.4 Top 3 and Top 5 Cytotoxic Drug Companies in United States Market, by Revenue in 2020
3.5 Companies Cytotoxic Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cytotoxic Drug Players in United States Market
3.6.1 List of Tier 1 Cytotoxic Drug Companies in United States
3.6.2 List of Tier 2 and Tier 3 Cytotoxic Drug Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Cytotoxic Drug Market Size Markets, 2021 & 2027
4.1.2 Injection
4.1.3 Solid Oral Dose Forms
4.1.4 Others
4.2 By Type - United States Cytotoxic Drug Revenue & Forecasts
4.2.1 By Type - United States Cytotoxic Drug Revenue, 2016-2021
4.2.2 By Type - United States Cytotoxic Drug Revenue, 2022-2027
4.2.3 By Type - United States Cytotoxic Drug Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Cytotoxic Drug Market Size, 2021 & 2027
5.1.2 Breast Cancer
5.1.3 Blood Cancer
5.1.4 Prostate Cancer
5.1.5 Respiratory/Lung Cancer
5.1.6 Other
5.2 By Application - United States Cytotoxic Drug Revenue & Forecasts
5.2.1 By Application - United States Cytotoxic Drug Revenue, 2016-2021
5.2.2 By Application - United States Cytotoxic Drug Revenue, 2022-2027
5.2.3 By Application - United States Cytotoxic Drug Revenue Market Share, 2016-2027
6 Cytotoxic Drug Companies Profiles
6.1 Roche
6.1.1 Roche Company Details
6.1.2 Roche Business Overview
6.1.3 Roche Cytotoxic Drug Introduction
6.1.4 Roche Cytotoxic Drug Revenue in United States Market (2016-2021)
6.1.5 Roche Recent Developments
6.2 Eli Lilly
6.2.1 Eli Lilly Company Details
6.2.2 Eli Lilly Business Overview
6.2.3 Eli Lilly Cytotoxic Drug Introduction
6.2.4 Eli Lilly Cytotoxic Drug Revenue in United States Market (2016-2021)
6.2.5 Eli Lilly Recent Developments
6.3 Celgene
6.3.1 Celgene Company Details
6.3.2 Celgene Business Overview
6.3.3 Celgene Cytotoxic Drug Introduction
6.3.4 Celgene Cytotoxic Drug Revenue in United States Market (2016-2021)
6.3.5 Celgene Recent Developments
6.4 Sanofi
6.4.1 Sanofi Company Details
6.4.2 Sanofi Business Overview
6.4.3 Sanofi Cytotoxic Drug Introduction
6.4.4 Sanofi Cytotoxic Drug Revenue in United States Market (2016-2021)
6.4.5 Sanofi Recent Developments
6.5 eisai
6.5.1 eisai Company Details
6.5.2 eisai Business Overview
6.5.3 eisai Cytotoxic Drug Introduction
6.5.4 eisai Cytotoxic Drug Revenue in United States Market (2016-2021)
6.5.5 eisai Recent Developments
6.6 Sumitomo Dainippon Pharma
6.6.1 Sumitomo Dainippon Pharma Company Details
6.6.2 Sumitomo Dainippon Pharma Business Overview
6.6.3 Sumitomo Dainippon Pharma Cytotoxic Drug Introduction
6.6.4 Sumitomo Dainippon Pharma Cytotoxic Drug Revenue in United States Market (2016-2021)
6.6.5 Sumitomo Dainippon Pharma Recent Developments
6.7 Merck
6.7.1 Merck Company Details
6.7.2 Merck Business Overview
6.7.3 Merck Cytotoxic Drug Introduction
6.7.4 Merck Cytotoxic Drug Revenue in United States Market (2016-2021)
6.7.5 Merck Recent Developments
6.8 Seattle Genetics
6.8.1 Seattle Genetics Company Details
6.8.2 Seattle Genetics Business Overview
6.8.3 Seattle Genetics Cytotoxic Drug Introduction
6.8.4 Seattle Genetics Cytotoxic Drug Revenue in United States Market (2016-2021)
6.8.5 Seattle Genetics Recent Developments
6.9 Takeda
6.9.1 Takeda Company Details
6.9.2 Takeda Business Overview
6.9.3 Takeda Cytotoxic Drug Introduction
6.9.4 Takeda Cytotoxic Drug Revenue in United States Market (2016-2021)
6.9.5 Takeda Recent Developments
6.10 Haosoh Pharma
6.10.1 Haosoh Pharma Company Details
6.10.2 Haosoh Pharma Business Overview
6.10.3 Haosoh Pharma Cytotoxic Drug Introduction
6.10.4 Haosoh Pharma Cytotoxic Drug Revenue in United States Market (2016-2021)
6.10.5 Haosoh Pharma Recent Developments
6.11 Novartis
6.11.1 Novartis Company Details
6.11.2 Novartis Business Overview
6.11.3 Novartis Cytotoxic Drug Introduction
6.11.4 Novartis Cytotoxic Drug Revenue in United States Market (2016-2021)
6.11.5 Novartis Recent Developments
6.12 AstraZeneca
6.12.1 AstraZeneca Company Details
6.12.2 AstraZeneca Business Overview
6.12.3 AstraZeneca Cytotoxic Drug Introduction
6.12.4 AstraZeneca Cytotoxic Drug Revenue in United States Market (2016-2021)
6.12.5 AstraZeneca Recent Developments
6.13 Jazz Pharma
6.13.1 Jazz Pharma Company Details
6.13.2 Jazz Pharma Business Overview
6.13.3 Jazz Pharma Cytotoxic Drug Introduction
6.13.4 Jazz Pharma Cytotoxic Drug Revenue in United States Market (2016-2021)
6.13.5 Jazz Pharma Recent Developments
6.14 Spectrum Pharma
6.14.1 Spectrum Pharma Company Details
6.14.2 Spectrum Pharma Business Overview
6.14.3 Spectrum Pharma Cytotoxic Drug Introduction
6.14.4 Spectrum Pharma Cytotoxic Drug Revenue in United States Market (2016-2021)
6.14.5 Spectrum Pharma Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Cytotoxic Drug Market Opportunities & Trends in United States Market
Table 2. Cytotoxic Drug Market Drivers in United States Market
Table 3. Cytotoxic Drug Market Restraints in United States Market
Table 4. Key Players of Cytotoxic Drug in United States Market
Table 5. Top Cytotoxic Drug Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Cytotoxic Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Cytotoxic Drug Revenue Share by Companies, 2016-2021
Table 8. Companies Cytotoxic Drug Product Type
Table 9. List of Tier 1 Cytotoxic Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Cytotoxic Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Cytotoxic Drug Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Cytotoxic Drug Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Cytotoxic Drug Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Cytotoxic Drug Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Cytotoxic Drug Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Cytotoxic Drug Revenue (US$, Mn), 2022-2027
Table 17. Roche Company Details
Table 18. Roche Business Overview
Table 19. Roche Cytotoxic Drug Product
Table 20. Roche Cytotoxic Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Roche Recent Developments
Table 22. Eli Lilly Company Details
Table 23. Eli Lilly Business Overview
Table 24. Eli Lilly Cytotoxic Drug Product
Table 25. Eli Lilly Cytotoxic Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Eli Lilly Recent Developments
Table 27. Celgene Company Details
Table 28. Celgene Business Overview
Table 29. Celgene Cytotoxic Drug Product
Table 30. Celgene Cytotoxic Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Celgene Recent Developments
Table 32. Sanofi Company Details
Table 33. Sanofi Business Overview
Table 34. Sanofi Cytotoxic Drug Product
Table 35. Sanofi Cytotoxic Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Sanofi Recent Developments
Table 37. eisai Company Details
Table 38. eisai Business Overview
Table 39. eisai Cytotoxic Drug Product
Table 40. eisai Cytotoxic Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. eisai Recent Developments
Table 42. Sumitomo Dainippon Pharma Company Details
Table 43. Sumitomo Dainippon Pharma Business Overview
Table 44. Sumitomo Dainippon Pharma Cytotoxic Drug Product
Table 45. Sumitomo Dainippon Pharma Cytotoxic Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Sumitomo Dainippon Pharma Recent Developments
Table 47. Merck Company Details
Table 48. Merck Business Overview
Table 49. Merck Cytotoxic Drug Product
Table 50. Merck Cytotoxic Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Merck Recent Developments
Table 52. Seattle Genetics Company Details
Table 53. Seattle Genetics Business Overview
Table 54. Seattle Genetics Cytotoxic Drug Product
Table 55. Seattle Genetics Cytotoxic Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Seattle Genetics Recent Developments
Table 57. Takeda Company Details
Table 58. Takeda Business Overview
Table 59. Takeda Cytotoxic Drug Product
Table 60. Takeda Cytotoxic Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Takeda Recent Developments
Table 62. Haosoh Pharma Company Details
Table 63. Haosoh Pharma Business Overview
Table 64. Haosoh Pharma Cytotoxic Drug Product
Table 65. Haosoh Pharma Cytotoxic Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Haosoh Pharma Recent Developments
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Cytotoxic Drug Product
Table 70. Novartis Cytotoxic Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Novartis Recent Developments
Table 72. AstraZeneca Company Details
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca Cytotoxic Drug Product
Table 75. AstraZeneca Cytotoxic Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 76. AstraZeneca Recent Developments
Table 77. Jazz Pharma Company Details
Table 78. Jazz Pharma Business Overview
Table 79. Jazz Pharma Cytotoxic Drug Product
Table 80. Jazz Pharma Cytotoxic Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 81. Jazz Pharma Recent Developments
Table 82. Spectrum Pharma Company Details
Table 83. Spectrum Pharma Business Overview
Table 84. Spectrum Pharma Cytotoxic Drug Product
Table 85. Spectrum Pharma Cytotoxic Drug Revenue in United States Market (2016-2021) & (US$ Million)
Table 86. Spectrum Pharma Recent Developments
List of Figures
Figure 1. Cytotoxic Drug Segment by Type
Figure 2. Cytotoxic Drug Segment by Application
Figure 3. United States Cytotoxic Drug Market Overview: 2020
Figure 4. United States Cytotoxic Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Cytotoxic Drug Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Cytotoxic Drug Revenue in 2020
Figure 7. By Type - United States Cytotoxic Drug Revenue Market Share, 2016-2027
Figure 8. By Application - United States Cytotoxic Drug Revenue Market Share, 2016-2027
Figure 9. Roche Cytotoxic Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Eli Lilly Cytotoxic Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Celgene Cytotoxic Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Sanofi Cytotoxic Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. eisai Cytotoxic Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Sumitomo Dainippon Pharma Cytotoxic Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Merck Cytotoxic Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Seattle Genetics Cytotoxic Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Takeda Cytotoxic Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Haosoh Pharma Cytotoxic Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Novartis Cytotoxic Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. AstraZeneca Cytotoxic Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Jazz Pharma Cytotoxic Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Spectrum Pharma Cytotoxic Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs